Best VPN 2025: NordVPN Tops VPN Service Providers Rankings U.S. Patent Office Issues Notice of Allowance for Nicox’s Latanoprostene Bunod in Normal Tension Glaucoma
Press Release U.S. Patent Office Issues Notice of Allowance for Nicox’s Latanoprostene Bunod in Normal…
ObsEva Initiates PRIMROSE 3 Bone Mineral Density Follow-Up Study in PRIMROSE 1 and PRIMROSE 2 Trial Participants
–Long-term follow-up study to evaluate bone mineral density in women completing at least 20 weeks…
MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings
NEWS RELEASE – REGULATED INFORMATION 27 April 2021, 7:00 a.m. CET IRVINE, CA, and HERSTAL,…
Sequana Medical Announces Annual and Extraordinary General Meetings of Shareholders on 27 May 2021
Publication of Annual Report 2020 GHENT, Belgium, April 27, 2021 (GLOBE NEWSWIRE) — Sequana Medical…
Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed.
Q1 net sales declined -2% (cc¹, +1% USD), due to prior year COVID-19 related forward…
Reata Announces FDA Accepted for Filing the NDA for Bardoxolone for the Treatment of Patients With Chronic Kidney Disease Caused by Alport Syndrome
Approximately 30,000-60,000 Patients in the United States Are Affected With Alport Syndrome, a Life-Threatening Disease With…
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS). Dear…
Travere Therapeutics to Report First Quarter 2021 Financial Results
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
MediWound to Report First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 5, 2021
YAVNE, Israel, April 26, 2021 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully integrated…
PDS Biotechnology Announces Conference Call and Webcast for First Quarter Financial Results
FLORHAM PARK, N.J., April 26, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Zymergen Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
EMERYVILLE, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Zymergen Inc. (“Zymergen”), one of the world’s…
Krystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB
PITTSBURGH, April 26, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
IRVINE, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
AGTC Announces Departure of Chief Scientific Officer
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
Aptose to Report First Quarter 2021 Financial Results and Hold Conference Call on Tuesday, May 4, 2021
SAN DIEGO and TORONTO, April 26, 2021 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO;…
Inventiva to participate at the 7th Annual Truist Securities Life Sciences Summit
Daix (France), April 26, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
ZIVO Bioscience Announces US Patent Office Notice of Allowance for Administration of Proprietary Algal Biomass to Support Immune Health
KEEGO HARBOR, Mich., April 26, 2021 (GLOBE NEWSWIRE) — ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech…
OSE Immunotherapeutics and Veloxis Pharmaceuticals Enter Into Global License Agreement to Develop, Manufacture, and Commercialize FR104, a CD28 Antagonist, in the Organ Transplantation Market
Agreement expands Veloxis’ product portfolio and the continued commitment to improving the lives of transplant…
Delisting of Kiadis will be effective on 25 May 2021
This is a joint press release by Sanofi Foreign Participations B.V. (the “Offeror”), Sanofi (“Sanofi”)…
UPDATE – Advaxis Announces Achievement of Second Milestone Under ADXS-HER2 Licensing Agreement with OS Therapies
Non-dilutive capital will support advancement of ADXS-HOT neoantigen program PRINCETON, N.J., April 26, 2021 (GLOBE…